Edesa Biotech, Inc. — Form D

Edesa Biotech, Inc. of MARKHAM, A6, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-05. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (47)

Showing 25 of 47 people.

NameRoleLocation
Jennifer ChaoDirectorOakville, A6
Lorin JohnsonDirectorRaleigh, NC
Paul PayDirectorMarkham, A6
Kathi NiffeneggerExecutive OfficerMarkham, A6
Patrick MarshallDirectorMarkham, A6
Patrick MarshallRelated PersonMarkham, A6
Sean MacDonaldDirectorMarkham, A6
Sean MacDonaldRelated PersonMarkham, A6
Pardeep NijhawanDirectorMarkham, A6
Pardeep NijhawanExecutive OfficerMarkham, A6
Pardeep NijhawanRelated PersonMarkham, A6
Stephen LemieuxExecutive OfficerMARKHAM, A6
Charles OlsonDirectorMarkham, A6
Charles OlsonRelated PersonMarkham, A6
Frank OakesDirectorMARKHAM, A6
David LiuDirectorMarkham, A6
David LiuRelated PersonMarkham, A6
Joan ChypyhaDirectorMarkham, A6
Joan ChypyhaRelated PersonMarkham, A6
Michael BrooksExecutive OfficerMarkham, A6
Michael BrooksRelated PersonMarkham, A6
Carlo SistilliDirectorMarkham, A6
Carlo SistilliRelated PersonMarkham, A6
Mark A McPartlandExecutive OfficerSouth San Francisco, CA
David Louis HillDirectorPort Hueneme, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2026-06-26D$3.5M$3.5M
2025-02-14D$15.0M$15.0M
2016-07-21D$6.8M$6.8M
2013-10-03D/A$12.0M$12.0M
2013-09-03D$12.0M
2013-04-11D$1.6M$1.6M
2013-01-15D$505K$505K
2012-10-31D$1.0M$1.0M

More